News

The bioindustrial manufacturing nonprofit BioMADE has announced its flagship facility will be in Maple Grove, confirming ...
Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here's how the company plans to expand.
Biotechnology company Amgen announced a $900 million manufacturing expansion in Ohio on Friday, bringing 350 new jobs to ...
Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its ...
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.
YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...
The Department of Defense is investing at least $80 million to turn a Hayward property into a pilot site for bioindustrial ...
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by ...
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...
Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of its patent for an innovative enzymatic method to ...